基于植物的纳米输送系统用于治疗炎症疾病
Catarina R Silva1, Amélia C F Vieira1,2, Ana Cláudia Paiva-Santos1,2
1Department of Pharmaceutical Technology, Faculty of Pharmacy of the University of Coimbra, University of Coimbra, 3000-548 Coimbra, Portugal.
Pharmaceutics
|February 27, 2026
概括
药用植物提供抗炎功效,但面临生物可用性挑战. 纳米技术增强了这些天然化合物,改善了治疗炎症疾病的输送和疗效.
科学领域:
- 药理学和纳米医学的研究.
- 自然产品化学 自然产品化学
- 免疫学 免疫学 免疫学
背景情况:
- 炎症是慢性疾病 (如心血管和自身免疫疾病) 的关键因素,对公共卫生构成重大挑战.
- 传统的抗炎药物有其局限性,包括副作用和目标特异性差.
- 药用植物及其化合物对抗炎症疗法有前途,但由于溶解度低和代谢快,生物可用性差.
研究的目的:
- 审查关于在纳米系统中封装的药用植物及其生物活性化合物用于炎症疾病的科学证据.
- 整合体外和体内研究,详细说明作用机制和纳米输送系统.
- 突出纳米医学在克服植物性抗炎药物的生物制药挑战方面的潜力.
主要方法:
- 关于体外和体外研究的综合文献综述.
- 分析各种药用植物及其生物活性植物化学化合物.
- 检查用于这些化合物的药物输送的不同纳米系统.
主要成果:
- 纳米系统显著提高了植物衍生抗炎化合物的特性.
- 优点包括持续释放,防腐,增强组织特异性和降低毒性.
- 将纳米系统纳入导致炎症状况更有利的治疗结果.
结论:
- 通过纳米系统输送的药用植物衍生化合物代表了对炎症疾病的有前途的治疗策略.
- 需要进一步的研究,以更深入地理解机制,并开发有针对性,刺激反应和临床可转化纳米疗法.
- 可持续和具有成本效益的植物纳米疗法的进展对于未来的临床应用至关重要.
相关概念视频
01:29Inflammatory Bowel Disease IV: Pharmacological Management
860
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
860
01:11Oral Drug Delivery Systems: Delayed-Release Systems
69
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...
69
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
604
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
604
01:24Modified-Release Drug Delivery Systems: Site-Targeted
51
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
51
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
972
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
972
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
59
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
59